VERACYTE
LIVE

Serial Number

97815151

Owner

Veracyte, Inc.

Attorney

ROSALEEN H. CHOU

Filing Date

Feb 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VERACYTE Trademark

Serial Number: 97815151

VERACYTE is a trademark filed by Veracyte, Inc. on February 28, 2023. The trademark is classified under Class 9 (Computers & Electronics). The application is currently pending registration.

Owner Contact Info

Veracyte, Inc. (31 trademarks)

7000 Shoreline Court
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

February 28, 2023

Registration Date

Not Registered

Published for Opposition

December 3, 2024

Goods & Services

Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Downloadable or recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; Computer hardware and downloadable and recorded computer software for use in data analysis in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Downloadable electronic publications in the nature of articles in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Downloadable reports in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; Scientific apparatus and instruments, namely, scientific laboratory research instruments for detecting disease, cancer, genetics, and pathogens

Filing History

SOU TEAS EXTENSION RECEIVED
Dec 18, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Nov 3, 2025 EX1G
SOU TEAS EXTENSION RECEIVED
Jun 12, 2025 EEXT
SOU EXTENSION 1 FILED
Jun 11, 2025 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2024 CNSA
DIVISIONAL PROCESSING COMPLETE
Nov 8, 2024 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 5, 2024 AITU
DIVISIONAL REQUEST RECEIVED
Oct 24, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Oct 24, 2024 ERTD
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 7, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 2, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 2, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 3, 2024 GNFN
FINAL REFUSAL E-MAILED
Jul 3, 2024 GNFR
FINAL REFUSAL WRITTEN
Jul 3, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 22, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 22, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 30, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2023 NWOS
NEW APPLICATION ENTERED
Mar 3, 2023 NWAP